Literature DB >> 12204015

Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy.

Joaquim Fernández-Solà, Josep María Nicolás, Josep Oriola, Emilio Sacanella, Ramón Estruch, Emanuel Rubin, Alvaro Urbano-Márquez.   

Abstract

BACKGROUND: Chronic alcohol abuse has a dose-dependent toxic effect on the myocardium, leading to alcoholic cardiomyopathy. The fact that only a minority of persons with chronic alcoholism have this condition suggests the possibility of a genetic vulnerability. In this context, polymorphism of the angiotensin-converting enzyme (ACE) gene has been implicated in cardiac dysfunction.
OBJECTIVE: To compare the ACE genotypes of alcoholic persons who have cardiomyopathy with those of comparable alcohol abusers who have normal cardiac function.
DESIGN: Case-control study over a 2-year period.
SETTING: An academic tertiary referral hospital in Barcelona, Spain. PATIENTS: 30 alcoholic men with symptomatic cardiomyopathy and 27 alcoholic men with normal cardiac function. MEASUREMENTS: Ethanol intake, cardiac status, left ventricular ejection fraction (LVEF), and ACE gene polymorphism.
RESULTS: The DD ACE genotype was present in 57% of alcoholic persons with an LVEF less than 0.50 and in 7% of those with normal cardiac function. Compared with persons who had an I allele, the odds ratio for development of left ventricular dysfunction in alcoholic persons with the DD genotype was 16.4.
CONCLUSIONS: Vulnerability to cardiomyopathy among chronic alcohol abusers is partially genetic and is related to presence of the ACE DD genotype. This finding demonstrates genetic susceptibility to alcohol-induced myocardial damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204015     DOI: 10.7326/0003-4819-137-5_part_1-200209030-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

1.  Alcoholic Cardiomyopathy: Multigenic Changes Underlie Cardiovascular Dysfunction.

Authors:  Dimitri Laurent; John G Edwards
Journal:  J Cardiol Clin Res       Date:  2014-01-24

Review 2.  [Alcohol consumption in women and the elderly : When does it induce heart failure?].

Authors:  S Pankuweit
Journal:  Herz       Date:  2016-09       Impact factor: 1.443

Review 3.  Imaging phenotype vs genotype in nonhypertrophic heritable cardiomyopathies: dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy.

Authors:  Subha V Raman; Cristina Basso; Harikrishna Tandri; Matthew R G Taylor
Journal:  Circ Cardiovasc Imaging       Date:  2010-11       Impact factor: 7.792

Review 4.  Cardiovascular risks and benefits of moderate and heavy alcohol consumption.

Authors:  Joaquim Fernández-Solà
Journal:  Nat Rev Cardiol       Date:  2015-06-23       Impact factor: 32.419

5.  DILATED CARDIOMYOPATHY IN A YOUNG MAN WITH POLYSUBSTANCE USE.

Authors:  Julia MacIsaac; Seonaid Nolan
Journal:  Can J Addict       Date:  2017-12

Review 6.  Alcohol consumption: can we safely toast to our health?

Authors:  Christopher Griffith; Douglas Bogart
Journal:  Mo Med       Date:  2012 Nov-Dec

Review 7.  Alcoholic cardiomyopathy.

Authors:  Gonzalo Guzzo-Merello; Marta Cobo-Marcos; Maria Gallego-Delgado; Pablo Garcia-Pavia
Journal:  World J Cardiol       Date:  2014-08-26

8.  Heart Failure Etiology Is Usually Pluricausal Whether or Not There is Associated Coronary Disease.

Authors:  Arthur L Klatsky; Sharon Gronningen; Natalia Udaltsova; Douglas Chartier; Somjot S Brar; James Schipper; Robert J Lundstrom
Journal:  Perm J       Date:  2007

Review 9.  Cardiac insulin resistance and microRNA modulators.

Authors:  Lakshmi Pulakat; Annayya R Aroor; Rukhsana Gul; James R Sowers
Journal:  Exp Diabetes Res       Date:  2011-07-31

10.  Angiotensin-converting enzyme genetic polymorphism: its impact on cardiac remodeling.

Authors:  Felipe Neves de Albuquerque; Andréa Araujo Brandão; Dayse Aparecida da Silva; Ricardo Mourilhe-Rocha; Gustavo Salgado Duque; Alyne Freitas Pereira Gondar; Luiza Maceira de Almeida Neves; Marcelo Imbroinise Bittencourt; Roberto Pozzan; Denilson Campos de Albuquerque
Journal:  Arq Bras Cardiol       Date:  2013-11-26       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.